Share Name Share Symbol Market Type Share ISIN Share Description
Scancell Holdings Plc LSE:SCLP London Ordinary Share GB00B63D3314 ORD 0.1P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.50 -3.08% 15.75 609,494 14:56:13
Bid Price Offer Price High Price Low Price Open Price
15.50 16.00 16.25 15.75 16.25
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -6.77 -1.21 125
Last Trade Time Trade Type Trade Size Trade Price Currency
16:35:23 UT 62,882 15.75 GBX

Scancell (SCLP) Latest News

More Scancell News
Scancell Investors    Scancell Takeover Rumours

Scancell (SCLP) Discussions and Chat

Scancell Forums and Chat

Date Time Title Posts
15/1/202120:20Using immunology to fight cancer.35,970
23/11/202008:53charts etc908
22/9/202008:26Scancell short thread6
25/4/202012:41Could this be the end of cancer?773

Add a New Thread

Scancell (SCLP) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Scancell trades in real-time

Scancell (SCLP) Top Chat Posts

Scancell Daily Update: Scancell Holdings Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell was 16.25p.
Scancell Holdings Plc has a 4 week average price of 12.75p and a 12 week average price of 10.25p.
The 1 year high share price is 18.25p while the 1 year low share price is currently 4.35p.
There are currently 791,917,828 shares in issue and the average daily traded volume is 1,151,154 shares. The market capitalisation of Scancell Holdings Plc is £124,727,057.91.
ivyspivey: Evening,my reply was mainly aimed at EE and when I referred to not being envious of anyone 1M shares in here believe it or not I was not aiming it at anyone specific as I know Inanaco and others are very proud of their holding which is good as it is only them that need to be pleased. It is aimed at the “ Golden Tickets” on many shares espousing that I take issue with as if it is only one share which is the answer to everyone’s dreams. It may not appear logical to sell shares when you can afford to wait and believe the prospects are good but that us what I certainly do as I may not like the timeline or simply think there are much better opportunities elsewhere especially within a much shorter timeline. There has been a huge increase in the share price of many Companys in the last 10 months including here and there us no one “ golden” route to success but many abd just because we take one oath way does not mean different choices are any better or wirse
emptyend: Just on the topic of market timing, I posted the following 21 days ago on another board:"I must say that I don't understand why people are selling here, given that the vast majority of them must only have bought a few months ago. The pitch when the company raised money was solely aimed at executing a farmout in there was no expectation of any significant news this year. Nothing has changed - so why are some of those who invested in summer now selling?One can only assume they are stupid (either to buy in the first place or to sell now...)....."At the time I posted, the share price had just traded at a low that was 20% below the summer placing price.Yesterday the share price gained 39% and it now trades at more than double the price of three weeks ago!.....The point here being that if you buy the shares in anticipation of a story that is going to take 18 months or more to play out, why would you sell after the first couple of chapters....?Completely different company and market here of course - but the same principle applies. At any time there could be some significant market-moving news - even if none is expected.
emptyend: Without getting drawn into the specifics of certain "pie in the sky" valuations or the technical details of the role that Covidity may play in the vaccine mix that is clearly going to be essential for us all, I feel strongly that there is the potential for a serious step-change in the share price based on a single piece of news....Imagine what might happen if the UK government (at some point over the coming months) decided to back acceleration of SN14 testing and/or promote a partnership with a capable manufacturer.....We know that Covidity should in theory have most/all of the competitive advantages of the AZ/Oxford vaccine (vs Pfizer) and might have others.....though, of course, safety and efficacy trump all of that and remain completely unproven. But a Government "vote of confidence" would be transformative for the share price.
inanaco: Tf ... read my history before you comment about low intervention ... what i said from the start ... was massive intervention but in the at risk groups inanaco Posted in: SCLP Posts: 33,092 Price: 5.85 No Opinion RE: Boris to self isolate?11 Mar 2020 09:34 If the Government can isolate the 20% ie anyone over the age of 60 .. then allow a pandemic to sweep the country so that the 80% have been exposed to the virus this creates the buffer to stop transmission in any future wave Ie, 80% is equivalent to heard immunity or a vaccine . That actually is the ideal scenario which keeps the ICU beds available for the .2% of the 80% who might develop complications. The issue is isolating the 20% for 6 months happy New Year and by the way unless you can produce a mathematical Formulae that links Share price, share issued, Mcap Cash in bank ... to explain Fiscal Dilution rather than Ip Dilution .... because the share price today is still higher than the last raise
inanaco: Bermuda Ref your Fake news ... from your amazing memory ... here is a Post YOU forgot about ..... Bermudashorts Posted in: SCLP Posts: 11,313 Price: 12.90 No Opinion RE: Scancell MODI1 - Solid Cancers13 Sep 2020 18:26 GF123 - but it's not a question of buying in at a better price than others with large holdings - the price of your large holding is irrelevant to mine. You may well have a lower average but you have also had a large amount of capital tied up that could have been providing you with returns elsewhere. Just a few weeks ago, I could have taken part in the placing at 5.5m - for the following 3 weeks I could have bought in the 6p range, sometimes at volume. I didn't but plenty did and good on them, they've called it right IMO. The point I'm really trying to make of course is that everybody has their own investment strategy based on their own personal circumstances. To claim that those who have sat on large investments here with a declining share price for 8 years somehow have superior investment skills and have now been proven right is odd IMO.
emptyend: "This gets funding to conduct phase 1 2 and 3 trials simultaneously.This is going to skyrocket once the yanks get involved even more."There is a significant amount of truth in this I think. Phase 1 is clearly key, but after that there is very substantial share price growth possible, especially if the indications are of a genuinely superior efficacy with virus mutations - which will become more of an issue by September 2021. If Moderna and Oxford are fine for the current virus, but don't do much for the future, then attention will shift quickly to vaccines that may give more durable protection. At present, US investors see Moderna as the only game in town - and there seem few holders outside of Redmile. If that changes and Scancell can get onto the radar of US investors in general in 2021, I can see the share price doubling/tripling every 6 months through to mid 2022.
thelogman: Good on you molj, am on my 3rd now. Two centre half's out. Bit like the toon not a full squad to choose from. Where do see sclp share price going short term I mean.As you know long term has no interest to me.
stocktastic: "Not exactly massive, however, it's a good sign" The only sign is that SCLP is trying to support the share price as it falls lower Quite why anyone expects success with SCLPs vaccine efforts when there are so many competing agents in development, I do not know!
miavoce: Seems pretty obvious that they selling at the moment is directly connected to the recent vaccine news and nothing to do with previous failing of the BoD or expectations that they will not achieve anything meaningful with the cash. Seems to me that the company has never been better placed to progress its platforms to a point where they can be monetised. Those exiting now due to the recent vaccine news probably didn't buy SCLP because of its cancer platforms and thus perceive that SCLP's potential value has diminished significantly now that a vaccine is available, whereas IMO the real value of SCLP lies in the cancer platforms. It also indicates that those exiting now have underestimated the need for a better C19 vaccines to be developed. Did Redmile invest because of the COVID vaccine work ? I would very much doubt it given that the published intent for the funds raised was to accelerate / expand the cancer platform trials. They know where the value is and it isn't C19. As I say, my opinion is that there has never been a better time to take a position in SCLP rather than this being time to exit. I'm sure some traders have used the recent vaccine news to take short positions on a number of C19 related stocks and SCLP may have been caught up in this - maybe even some on this board have done so....
profit master: How miffed must Redmile be at the current share price the could of done their funding deal between 10 / 11p. Maybe this is why the BOD were so keen to get this deal over the line they probably expected the share price to drift with no substantial news due any time soon. They have the cash in the bank and time on their side now. Good on the BOD. Can't really see any upside until well into next year.
Scancell share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210115 21:29:57